* Mild to moderate patients with AD who are free of life-threatening disease and who do not require
lipid-lowering treatment according to current guidelines.~* NINCDS/ADRDA criteria for probable AD.~*
Mini-Mental-State-Exam (MMSE) score between 12 and 26.~* Stable medical condition for 3 months prior to the
screening visit.~* Age greater than or equal to 50 years, and no upper age limit.~* Lives in a community
dwelling, not in a nursing home.~* Stable doses of (non-excluded) medications with central nervous system
activity for 4 weeks prior to the screening visit.~* Physical condition acceptable for the study as confirmed
by medical history, physical exam, neurologic exam and clinical laboratory tests.~* Informant/study partner
available and willing to accompany participant to all scheduled visits and complete informant-based assessments
and to supervise administration of study medications.~* Fluent in English or Spanish.~* Modified Hachinski is
less than or equal to 4.~
